Basic Information
Nephrolytics Develops AI Clinical Assessment Platform to Provide Advanced, Actionable Insights Through an Integrated Platform. The company’s platform offers enhanced clinical decision support, workflow optimization, data-informed decision-making, strategic financial planning, and more, enabling patients with chronic kidney disease to receive proactive and personalized care.
Nephrolytics, Inc.
Idaho,United States of America
15~50 people
January 01, 2023
info@nephrolytics.ai

